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Figure 1. Mrs. S's initial EKG showing ST segment elevations in leads V2-V6.

Introduction
Takotsubo cardiomyopathy (TC), also known as
stress cardiomyopathy, and broken heart syndrome
is characterized by transient left ventricular (LV) apical
akinesis with symptoms mimicking acute coronary
syndrome. The first case was described by Sato et al.
in Japan.1 The Japanese word “takotsubo” translates to
“octopus pot” describing the shape of the left ventricle
during systole. TC can be triggered by a “broken heart”
including death of a loved one, constant anxiety,
surgery, or critical illness etc. Prevalence is around 2%
to 3% with over 90% in postmenopausal women aged
between 58 and 75. Its pathogenesis remains unclear.
Some postulated that excess catecholamine released
during stress can induce an exaggerated sympathetic
response precipitating severe, reversible LV dysfunction
in patients without coronary disease.2 Whether there is a
genetic component is not well understood. There are a
few reported cases of Takotsubo in family members, one
case of two sisters and another mother-daughter pair.3,4
Recurrence of the syndrome in the same patient, although
rare, can occur and suggests a genetic predisposition.5
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Majority of patients regain normal ventricular function
within one to four weeks if they survive the acute episode.
Hospital mortality rates range from 0 to 8 %. However,
one major complication is the risk of intraventricular
thrombus formation and systemic embolization. Data
is lacking to guide anticoagulation for LV thrombus
prevention in patients with stress cardiomyopathy.

Case Presentation
Mrs. S is a 62 year old woman with a prior history of TC
with full recovery, hyperlipidemia, and gastroesophageal
reflux disease presented with chest pain radiating to her
left shoulder. She was under significant financial stress
during that week. Her pain was unrelieved with aspirin
or sublingual nitroglycerin. In the emergency room, her
electrocardiogram showed ST segment elevations in
leads V2-V6 (Figure 1) with Troponin T 1.49ng/mL. She
was immediately started on heparin and nitroglycerin
drips and rushed to the catheterization laboratory.
Coronary angiography did not reveal significant coronary
disease but incidentally found elevated pulmonary
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wedge pressures. Upon transfer to the cardiac intensive
unit, Mrs. S became hypotensive and norepinephrine
was started. Her transthoracic echocardiogram (TTE)
revealed moderately decreased LV systolic function
with an estimated ejection fraction (EF) of 35%, with
segmental wall motion abnormalities, mid and distal
akinesis of the LV and hyperkinesis of basal LV. There was
a late-peaking LV outflow tract gradient of 77 mm Hg
consistent with severe, dynamic left ventricular outflow
tract (LVOT) obstruction.

Discussion

She had a prior episode of TC when her husband passed
away three years ago. She also has a twin sister who
suffered from TC a year ago when she lost her job.
Unlike Mrs. S, she did not fully recover and required long
term heart failure management.

Familial cases of stress cardiomyopathy are very rare.
One case reports a 64 year old female diagnosed with
TC when presented with sudden chest pain, elevated
cardiac enzymes and ST elevations. Her elder sister
developed TC one year prior with similar presenting
symptoms. There are also several other reports of
sisters with TC. Studies on genetic polymorphisms for
Takotsubo have been inconclusive. One study found an
association between patients with TC and beta 1 adrenoreceptor gene polymorphisms, suggesting possible
genetic disease modifiers for developing TC.6 However,
a large Australian study did not find any association
between functional variants in the G-protein-coupled
receptor kinase 5 genes or the β1-adrenergic receptor
with the occurrence of the syndrome7.

Differential Diagnosis
Takotsubo was at the top of our differential given the
patient’s personal and family history and recent financial
stress. The lack of significant coronary disease on LHC
clinched the diagnosis of stress cardiomyopathy.

Outcome and Follow-Up
Mrs. S was diagnosed with TC with LVOT obstruction
complicated by cardiogenic shock. The LVOT obstruction
made treatment particularly difficult given that inotropes
can worsen the obstruction. Due to tachycardia, she
was switched from norepinephrine to phenylephrine.
On day 2, Mrs. S developed hypoxia and was intubated
and rushed to cath lab for intra-aortic balloon pump
insertion. However, the procedure was aborted when
her right heart catheterization numbers and vital signs
improved. She continued to recover on supportive care
and was successfully extubated on day 8. Her repeat
TTE showed recovery of systolic function (EF 70%) but
revealed a 2.3 x 1.1 cm LV apical thrombus. Heparin drip
and warfarin were initiated. On day 9, patient reported
blurry vision and a left visual field defect that were
persistent despite wearing her glasses. Although her
head CT scan was negative for mass effect or stroke,
her head MRI revealed a recent punctate infarction in
the right occipital lobe. In addition, on day 11, Mrs. S
developed intractable back pain and a CT Abdomen and
Pelvis showed new wedge-shape perfusion defects in
the right kidney consistent with infarcts.
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This case has multiple teaching points. First, it is one
of the few cases of a patient with a recurrence of
Takotsubo as well as a twin sister who suffered from the
same syndrome suggesting a possible genetic predisposition to stress cardiomyopathy. Second, it emphasizes
the risk of intraventricular thrombus formation and
systemic embolization in patients with TC and raises the
important discussion on whether these patients should
receive prophylactic anticoagulation.

More research is also needed to understand the risk
and prevention of thromboembolism in TC patients.
In a Japanese study of 21 patients with Takosubo, they
found that 3 patients (14%) suffered thromboembolism,
one of which had a LV thrombus. They recommended
prophylactic anticoagulation for TC patients with severe
wall motion abnormality to prevent cardioembolic stroke8.
There are scant data on criteria for prophylactic anticoagulation to prevent thromboembolism in TC. In patients
with myocardial infarction, it has been found that
reperfusion therapy and anticoagulant therapy lowers the
risk of thrombus formation, which would also lower the
risk of thrombus embolization. In a 1993 meta-analysis
in patients who had an anterior MI, the odds ratio of LV
thrombus in patients treated with fibrinolytic was half
compared to no fibrinolytic therapy.9 The same study
also showed that initiating heparin early and for more
than 48 hours lowered the rate of thrombus formation.
In a randomized control trial, high dose (12,500 units)
subcutaneous unfractionated heparin given every 12
hours for 10 days was associated with lower incidence
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of LV thrombus compared to low dose (5,000 units).
(11 versus 32 percent).10 Amongst patients who already
developed a LV thrombus, anticoagulation with
warfarin lowers the risk of thrombus embolization. An
observational study of 43 patients with LV thrombus after
MI found no embolic events in the 25 patients treated
with anticoagulation compared to 7 of 18 untreated
patients having an embolic event, all occurring within
4 months. 11 Although no studies have been done
on patients with stress cardiomyopathy, it would be
reasonable to initiate anticoagulation in patients with
severe LV dysfunction to prevent thrombus.

Key Points
1. Familial and recurrent cases suggest a genetic
predisposition to Takotsubo cardiomyopathy.
2. Patients suffering from stress cardiomyopathy with
severe LV dysfunction may benefit from early anticoagulation to prevent thromboembolism.
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